The first Covid-19 vaccine developed in the Southern Hemisphere enters phase 1 human trials in Adelaide

The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to eight weeks, according to the Australian Financial Review.

“From there we will look to commence phase II and III trials straight away,” the company’s chairman told the paper. “The follow-on trials will need to go broader into the elderly and people with chronic disease, because they’re the most vulnerable to COVID infection.”

Link to the article: https://www.vice.com/en_au/article/3azvbj/how-many-coronavirus-vaccines-tracker